Cosmo Pharmaceuticals N.V. (COPN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Cosmo Pharmaceuticals N.V.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
325
First IPO Date
March 12, 2007
Key Executives
| Name | Title | Pay | Year Born |
| Giovanni Di Napoli | Chief Executive Officer & Director | 1.36M | 1974 |
| Mauro Severino Ajani | Founder & Non-Executive Director | 47,379 | 1955 |
| Niall Donnelly | Executive Vice President of Corporate Governance, Chief Sustainability Officer & Executive Director | 381,683 | 1972 |
| Alessandro E. Della Cha | Non Executive Chairman | 385,718 | 1963 |
| Andrea Cherubini | Chief AI Officer | 0 | 1973 |
| Davide Malavasi | Senior Vice President, Global Manufacturing, Qualified Person & Technical Director | 0 | 1973 |
| Silvia Miliani | Chief HR Officer | 0 | 1971 |
| Svetlana Sigalova | Chief Financial Officer | 0 | 1982 |
| Federico Sommariva | Chief Legal Counsel | 0 | 1985 |
| Luigi Longo | Chief Scientific Officer | 0 | 1979 |
| Ngo Dinh Nhan | President of Cosmo Intelligent Medical Devices | 0 | 1979 |
AD
Description
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
AD
